Paperpal Prime Logo

Neurology and Therapy : Impact Factor & More

eISSN: 2193-6536pISSN: 2193-8253
JournalOpen Access

Key Metrics

CiteScore
5.3
Eigenfactor
0.001 - 0.005
H-Index
29
Impact Factor
< 5
SJR
Q2Neurology
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neurology and Therapy

Neurology and Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGER LONDON LTD
Language English
Frequency Semi-annual
Article Processing ChargesEUR 5500 | USD 6850 | GBP 4700
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencySemi-annual
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Neurology and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neurology and Therapy

Steroid-Sparing Effect of Efgartigimod in Generalized Myasthenia Gravis: Study Protocol for a Single-Arm, Open-Label Clinical Trial.
  • 29 Jun 2026
  • Neurology and therapy
Screening on the Paretic Side is Superior for Detecting Possible Sarcopenia in Individuals After Chronic Stroke: Preliminary Findings.
  • 28 Jun 2026
  • Neurology and therapy
Spectral Composition of Ambient White Light Modulates Photophobia and Headache Intensity During Migraine Attacks.
  • 21 Jun 2026
  • Neurology and therapy
Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial.
  • 20 Jun 2026
  • Neurology and therapy
ECAS-Based Neuropsychological Phenotyping in Amyotrophic Lateral Sclerosis: A Retrospective Study Comparing Different Algorithms.
  • 20 Jun 2026
  • Neurology and therapy
Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: The ORCHESTRA Study.
  • 20 Jun 2026
  • Neurology and therapy
Steroid-Sparing Effect of Efgartigimod in Generalized Myasthenia Gravis: Study Protocol for a Single-Arm, Open-Label Clinical Trial.
  • 29 Jun 2026
  • Neurology and therapy
Screening on the Paretic Side is Superior for Detecting Possible Sarcopenia in Individuals After Chronic Stroke: Preliminary Findings.
  • 28 Jun 2026
  • Neurology and therapy
Spectral Composition of Ambient White Light Modulates Photophobia and Headache Intensity During Migraine Attacks.
  • 21 Jun 2026
  • Neurology and therapy
Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial.
  • 20 Jun 2026
  • Neurology and therapy
ECAS-Based Neuropsychological Phenotyping in Amyotrophic Lateral Sclerosis: A Retrospective Study Comparing Different Algorithms.
  • 20 Jun 2026
  • Neurology and therapy
Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: The ORCHESTRA Study.
  • 20 Jun 2026
  • Neurology and therapy

FAQs on Neurology and Therapy